Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Icecure Medical (ICCM – Research Report) yesterday and set a price target ...

We recently compiled a list of the 8 Hot Growth Stocks To Buy According to Hedge Funds. In this article, we are going to take ...

An FDA panel on Thursday endorsed a cryoablation system as an alternative to surgery for some early breast cancer patients.

Yi Chen, an analyst from H.C. Wainwright, reiterated the Buy rating on Icecure Medical (ICCM – Research Report). The associated price ...

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...

A combination of transarterial embolization and percutaneous CT-guided ablation was an effective, well-tolerated, and safe ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM; the "Company"), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced that its CEO & President, Olav ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

Statement 25: Clinicians should consider thermal ablation as an alternate approach for the management of cT1a solid renal masses <3 cm in size. For patients who elect thermal ablation, a percutaneous ...

Dr Tina Willits was given just 24 months to live after a cancer diagnosis. Against all odds, she's now in remission.

AtriCure stock rose more than 16% on news of plans to expand into pulsed field ablation, a tech that could potentially better treat AFib.

Since rolling out its pulsed field ablation system for treating atrial fibrillation earlier this year, Boston Scientific has ...